NextStep Robotics is developing the first effective treatment option for foot drop to help stroke survivors.
NextStep Robotics provides clinics the ability to offer personalized robotic therapy to patients through adaptive software that provides a personalized assist as needed approach. This is the first ever clinically proven option to effectively treat foot drop. Their robot is easy to use and designed to be run by lower skilled clinic staff freeing up therapists to focus on more hands modalities. As they collect more data, the software will transition into an AI-based system to assess and assigns training protocols optimized for each patient’s deficit. The improved outcomes will allow clinics to provide reimbursable therapy using existing CPT codes for gait training on a patient base they currently have no treatment for. The device will be registered with the FDA as a Class 1 Exercise Device; and so, it can be sold and used WITHOUT FDA APPROVAL. Allowing NextStep Robotics to immediately generate revenue through: 1) Direct sales/leasing of robots; 2) Subscription to software service; 3) Service contracts.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 21, 2019 | Grant | $1M | 1 | National Institutes of Health | — | Detail |
May 14, 2019 | Seed | $600K | 1 | — | — | Detail |
Feb 6, 2018 | Seed | $0.90M | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Institutes of Health | Yes | Grant |
UM Ventures | — | Seed |
TEDCO | — | Seed |